Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-market Surveillance Study of Altera™ Minimally Invasive Articulating Expandable Spacer in a TLIF Interbody Fusion Device

NCT03162666 is registered in ClinicalTrials.gov with Globus Medical Inc as lead sponsor.

NCT NCT03162666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03162666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-market Surveillance Study of Altera™ Minimally Invasive Articulating Expandable Spacer in a TLIF Interbody Fusion Device
Lead sponsor
Globus Medical Inc
Phase
Observational
Overall status
Withdrawn
Start date
February 28, 2017
Completion date
November 6, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease